Collaborate Disseminate
The results of a fascinating clinical trial challenge popular assumptions regarding “safer” strains of cannabis. The research found higher levels of cannabidiol (CBD) do not negate any potential adverse effects from smoking cannabis.
Category: Health & Wellbeing, Lifestyle
Tags: Cannabis, Marijuana, Psychedelic Medicine, Drugs, King’s College London
Continue reading Trial finds increasing CBD levels does not make cannabis safer
In a stunningly close result, voters in Colorado have passed the most progressive drug reform measure ever seen in the United States. Known as Proposition 122, the measure creates a regulatory framework for psychedelic clinics to operate in the state a… Continue reading Colorado voters pass historic psychedelic decriminalization act
The year is 2035. The weekend is looming. You’re thinking maybe some fun down at the beach with friends is on the cards. It’s not really looking like an alcohol-fueled gathering so instead of going to the liquor store you swing by a psychedelic clinic … Continue reading The ideological war at the heart of the psychedelic renaissance
Research into clinical uses for psychedelics has proliferated in recent years, but despite the constant stream of “psychedelic renaissance” news, the vast majority of studies remain in early, preliminary stages. Apart from one notable modality (MDMA-as… Continue reading The world’s first Phase 3 psilocybin clinical trial is about to commence
Research into clinical uses for psychedelics has proliferated in recent years, but despite the constant stream of “psychedelic renaissance” news, the vast majority of studies remain in early, preliminary stages. Apart from one notable modality (MDMA-as… Continue reading The world’s first Phase 3 psilocybin clinical trial is about to commence
Research into clinical uses for psychedelics has proliferated in recent years, but despite the constant stream of “psychedelic renaissance” news, the vast majority of studies remain in early, preliminary stages. Apart from one notable modality (MDMA-as… Continue reading The world’s first Phase 3 psilocybin clinical trial is about to commence
New research from a team of economists has estimated the legalization of medical and recreational cannabis over the past 25 years has cost pharmaceutical companies billions of dollars in lost sales. And, if the US were to legalize cannabis across the w… Continue reading Cannabis legalization in US projected to cost big pharma billions
New research from a team of economists has estimated the legalization of medical and recreational cannabis over the past 25 years has cost pharmaceutical companies billions of dollars in lost sales. And, if the US were to legalize cannabis across the w… Continue reading Cannabis legalization in US projected to cost big pharma billions
For almost a century popular culture has been filled with images of lazy, unmotivated “stoners” who do little more with their lives than smoke cannabis, but a new study from a team of UK researchers is busting that long-held myth. Across a series of la… Continue reading Study debunks “stoner” myth that cannabis users are lazy & unmotivated
A new study published in JAMA Psychiatry has reported results from the first ever double-blind, placebo-controlled trial testing psilocybin-assisted psychotherapy to treat alcohol use disorder. The headline results are promising, finding nearly half of… Continue reading Psilocybin alcoholism trial highlights problem for psychedelic science